Cancer Specialists Gather to Discuss Innovations in Research and Treatment
Article date: June 3, 2016
As many as 30,000 cancer specialists from around the world are gathering in Chicago this week for the 52nd annual meeting of the American Society of Clinical Oncology (ASCO). The event runs from June 3rd through June 7th. It features the latest advances in clinical cancer research.
News announced during each meeting includes the latest findings from cancer clinical trials, including new drug studies, which could change current standards of care.
This year’s meeting will focus on the theme Collective Wisdom: The Future of Patient-Centered Care and Research, emphasizing that the combined knowledge from various disciplines, cancer types, treatment approaches, and big data technologies is essential to progress.
Get the headlines from the conference from our content partners at CURE. You can also follow along on Twitter using the hashtag #ASCO16.
- Adding Darzalex to Drug Combination Improves Outcomes in Relapsed Multiple Myeloma
- Opdivo Improves Overall Survival, Objective Response Rate in Head and Neck Cancer
- Targeted Drug Binimetinib Slows Disease Progression in NRAS-Mutated Melanoma
- At End of Life, Aggressive Cancer Treatment Often Eclipses Recommended Palliative Care
- Extending AI Therapy Reduces Recurrence in HR-Positive Breast Cancer
- Adding Chemo to Radiotherapy Improves Outcomes for Older Adults With Glioblastoma
- After Surgery for Ovarian Cancer, Combine Intraperitoneal and Intravenous Chemotherapy
- Wearable Activity Monitors May Provide Deeper Insight Into Cancer Patient Well-Being
- Chemotherapy Combination After Surgery Improves Survival in Pancreatic Cancer
- Palliative Care Benefit Extends to Caregivers, New Study Shows
- Keytruda Raises Hope of Conquering Advanced Melanoma
- Patients With Left-Sided Metastatic Colorectal Cancer Live Longer
Thank you for your feedback.